A multi-test planning model for risk based statistical quality control strategies

被引:11
作者
Westgard, Sten A. [1 ]
Bayat, Hassan [2 ]
Westgard, James O. [1 ,3 ]
机构
[1] Westgard QC Inc, Madison, WI 53717 USA
[2] Sina Med Lab, Qaem Shahr, Iran
[3] Univ Wisconsin, Sch Publ Hlth, Madison, WI USA
关键词
Statistical Quality Control; Risk based SQC strategy; Frequency of QC; Run size; QC schedule; QC rules; Multi-rule QC; Multi-stage QC; Multi-test analyzer;
D O I
10.1016/j.cca.2021.09.020
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Efforts to improve QC for multi-test analytic systems should focus on risk-based bracketed SQC strategies, as recommended in the CLSI C24-Ed4 guidance for QC practices. The objective is to limit patient risk by controlling the expected number of erroneous patient test results that would be reported over the period an error condition goes undetected. Methods: A planning model is described to provide a structured process for considering critical variables for the development of SQC strategies for continuous production multi-test analytic systems. The model aligns with the principles of the CLSI C24-Ed4 "roadmap" and calculation of QC frequency, or run size, based on Parvin's patient risk model. Calculations are performed using an electronic spreadsheet to facilitate application of the planning model. Results: Three examples of published validation data are examined to demonstrate the application of the planning model for multi-test chemistry and enzyme analyzers. The ability to assess "what if" conditions is key to identifying the changes and improvements that are necessary to simplify the overall system to a manageable number of SQC procedures. Conclusions: The planning of risk based SQC strategies should align operational requirements for workload and reporting intervals with QC frequency in terms of the run size or the number of patient samples between QC events. Computer tools that support the calculation of run sizes greatly facilitate the planning process and make it practical for medical laboratories to quickly assess the effects of critical variables.
引用
收藏
页码:216 / 223
页数:8
相关论文
共 19 条
[1]  
[Anonymous], QUALITY GOAL INDEX
[2]   Patient-Based Real Time QC [J].
Badrick, Tony ;
Bietenbeck, Andreas ;
Katayev, Alex ;
van Rossum, Huub H. ;
Cervinski, Mark A. ;
Loh, Tze Ping .
CLINICAL CHEMISTRY, 2020, 66 (09) :1140-1145
[3]  
Bayat H, 2017, J APPL LAB MED, V2, P211, DOI 10.1373/jalm.2017.023192
[4]   Biological Variation Estimates Obtained from 91 Healthy Study Participants for 9 Enzymes in Serum [J].
Carobene, Anna ;
Roraas, Thomas ;
Solvik, Una Orvim ;
Sylte, Marit Sverresdotter ;
Sandberg, Sverre ;
Guerra, Elena ;
Marino, Irene ;
Jonker, Niels ;
Barla, Gerhard ;
Bartlett, William A. ;
Fernandez-Calle, Pilar ;
Diaz-Garzon, Jorge ;
Tosato, Francesca ;
Plebani, Mario ;
Coskun, Abdurrahman ;
Serteser, Mustafa ;
Unsal, Ibrahim ;
Ceriottil, Ferruccio .
CLINICAL CHEMISTRY, 2017, 63 (06) :1141-1150
[5]  
Clinical and Laboratory Standards Institute, 2016, C24ED4 CLSI, V4
[6]   A Survey of Sigma Metrics across Three Academic Medical Centers [J].
Feldhammer, Matthew ;
Brown, Megan ;
Colby, Jennifer ;
Bryksin, Janetta ;
Milstid, Bryan ;
Nichols, James H. .
JOURNAL OF APPLIED LABORATORY MEDICINE, 2021, 6 (05) :1264-1275
[7]   Assessing the Impact of the Frequency of Quality Control Testing on the Quality of Reported Patient Results [J].
Parvin, Curtis A. .
CLINICAL CHEMISTRY, 2008, 54 (12) :2049-2054
[8]   Practical application of Westgard Sigma rules with run size in analytical biochemistry processes in clinical settings [J].
Peng, SongQing ;
Zhang, JinFei ;
Zhou, WuQiong ;
Mao, WeiLin ;
Han, Zhong .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (03)
[9]   Quality control limits: Are we setting them too wide? [J].
Schmidt, Robert L. ;
Walker, Brandon S. ;
Pearson, Lauren N. .
CLINICA CHIMICA ACTA, 2018, 486 :329-334
[10]  
Westgard J O., 2011, Six Sigma - Risk Analysis